Quince Therapeutics, Inc. (QNCX): 8-K filed Aug 14, 2026

Form type

8-K

Filing date

Aug 14, 2026

Accession number

0001193125-26-350568

Filer

Quince Therapeutics, Inc. (CIK 1662774)